Schizophrenia Management Guidelines

Initial Treatment Approach

The American College of Psychiatry recommends initiating antipsychotic monotherapy immediately after ≥1 week of psychotic symptoms causing distress or functional impairment, starting with risperidone 1-2 mg/day or olanzapine 7.5-10 mg/day as first-line options 1, 2
Treatment should be started after one week or more of psychotic symptoms with associated distress or functional impairment, or earlier if symptoms cause severe distress or pose safety concerns to self or others 1, 3

The initial antipsychotic choice must be made collaboratively with the patient based on side-effect and efficacy profiles 1, 3
For first-episode patients, risperidone should be started at 1 mg twice daily, titrated to a target range of 1.25-3.5 mg/day 2

Administer the first antipsychotic at therapeutic dose for at least 4 weeks before assessing efficacy 1, 2, 3
Treatment effectiveness should be assessed early with a proactive approach, with trials lasting 4-6 weeks at therapeutic doses for first-episode patients 1, 2

If significant positive symptoms persist after 4 weeks at therapeutic dose with good adherence, switch to a second antipsychotic with a different pharmacodynamic profile 1, 3
If positive symptoms remain significant after a second adequate 4-week trial at therapeutic dose, reassess diagnosis and contributing factors, then initiate clozapine 1, 2

Before starting any antipsychotic, obtain BMI, waist circumference, blood pressure, HbA1c, glucose, lipids, prolactin, liver function tests, urea and electrolytes, full blood count, and electrocardiogram 4, 2
Fasting glucose should be rechecked at 4 weeks, and BMI, waist circumference, and blood pressure should be monitored weekly for 6 weeks 4

Offer lifestyle advice and prescribe metformin prophylactically when starting olanzapine or clozapine to manage cardiometabolic side effects 4, 2
Akathisia should be managed with dose reduction first, or switch to quetiapine or olanzapine, and alternatively, add propranolol 10-30 mg two to three times daily 4

Antipsychotic medication must be combined with psychosocial interventions, including coordinated specialty care programs, psychoeducation, cognitive-behavioral therapy for psychosis, family interventions, social skills training, and supported employment services 5, 2
Cognitive-behavioral therapy for psychosis is the cornerstone treatment for anxiety symptoms in schizophrenia, with a Level 1B recommendation 5

First-episode patients must receive maintenance pharmacological treatment for 1-2 years after the initial episode, with continued treatment with the same medication if symptoms have improved 2
The healthcare provider should periodically reevaluate long-term usefulness for the individual patient 1

Use a non-judgmental supportive approach with information and education, and co-work with specialist substance use disorder services to manage substance use comorbidities 4
For tobacco cessation, offer varenicline, bupropion, or nicotine replacement therapy, and for alcohol use disorder, naltrexone has shown efficacy 4